The biggest COVID headline today is Merck’s announcement that it is seeking FDA approval (emergency use authorization) for its antiviral therapeutic molnupiravir, after clinical trial results showed the medication is as an highly effective treatment for COVID-19, the disease caused by SARS-CoV-2 infection.